The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein - Abstract

Johns Hopkins University, 3400 N Charles St, Baltimore, MD, United States.

The Cancer/Testis Antigens (CTAs) are an important group of heterogeneous proteins that are predominantly expressed in the testis in the normal human adult but are aberrantly expressed in several types of cancers. Prostate-Associated Gene 4 (PAGE4) is a member of the CT-X family of CTAs that in addition to testis, is highly expressed in the fetal prostate, and may also play an important role both in benign and malignant prostate diseases. However, the function of this gene remains poorly understood. Here, we show that PAGE4 is a highly (100%) intrinsically disordered protein (IDP). The primary protein sequence conforms to the features of a typical IDP sequence and the secondary structure prediction algorithm metaPrDOS strongly supported this prediction. Further, SDS gel electrophoresis and analytical size exclusion chromatography of the recombinant protein revealed an anomalous behavior characteristic of IDPs. UV circular dichroism (CD) and NMR spectroscopy confirmed that PAGE4 is indeed a highly disordered protein. In further bioinformatic analysis, the PredictNLS algorithm uncovered a potential nuclear localization signal (NLS) while the algorithm DBS-Pred returned a 99.1% probability that PAGE4 is a DNA binding protein. Consistent with this prediction, biochemical experiments showed that PAGE4 preferentially binds a GC-rich sequence. Silencing PAGE4 expression induced cell death via apoptosis and in mice carrying PCa xenografts, siRNA-mediated knockdown of the PAGE4 mRNA attenuated tumor growth in vivo. Furthermore, overexpressing PAGE4 protected cells from stress-induced death. To our knowledge, PAGE4 is the first example of a CTA that is an IDP with an anti-apoptotic function.

Written by:
Zeng Y, He Y, Yang F, Mooney S, Getzenberg R, Orban J, Kulkarni P.   Are you the author?

Reference: J Biol Chem. 2011 Feb 25. Epub ahead of print.
doi: 10.1074/jbc.M110.210765

PubMed Abstract
PMID: 21357425

UroToday.com Prostate Cancer Section

email news signup